Pew Comments on FDA Draft Guidance Documents on Compounded Copies of Approved Drugs

Speeches and Testimony October 11, 2016 Read time:

Projects: Drug Safety

The Pew Charitable Trusts offered comments on draft guidance documents issued by the Food and Drug Administration in July 2016 regarding compounded drugs that are essentially copies of commercially available or approved drugs. The proposed guidance would preserve the FDA’s approval process, which is critical to protecting patient safety, while allowing important exceptions under limited, specific circumstances, including when a patient has a clinical need for a customized formulation and when FDA-approved drugs are in shortage.

Downloads Pew Comments on FDA Draft Guidance Documents on Compounded Copies of Approved Drugs (PDF)

Downloads Pew Comments on FDA Draft Guidance Documents on Compounded Copies of Approved Drugs (PDF)

MORE FROM PEW

A woman and her grandchildren on a sunny afternoon.

Courts Can Do More to Help Families Seeking Guardianship

Sunlight streams into the blue waters of a vibrant coral reef. Yellow, black and blue, and orange fish swim near red, green and bright coral.

To Save Nature, Global Community Moves to Fund New Plan

Four yellow school buses emit smoke as they travel a road crowded with cars, construction vehicles, and scaffolding.

States Race to Win Federal Clean School Bus Grants

A photo illustration of an empty defendant’s chair, indicating that the person did not show for a virtual hearing, and the plaintiff’s lawyer sitting in a chair beside it. The one person faces forward toward an iPad with a gavel. The illustration has a blue background that shows the exterior of a courthouse.

Debt Collection Cases Continued to Dominate Civil Dockets